Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin corrosion: Not corrosive for Eth Oxanoate 369 Crude based on read across from Ethyl 2-methyl-3-pentenoate, which was tested in a study according to OECD TG 431.
Skin irritation: Not irritating for Eth Oxanoate 369 Crude based on read across from Ethyl 2-methyl-3-pentenoate, which was tested in a study according to OECD TG 439.
Eye irritation: Not irritating for Eth Oxanoate 369 Crude based on read across from Ethyl 2-methyl-3-pentenoate, which was tested in a study according to OECD TG 438.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
First the executive summaries of the in vitro skin irritation (OECD TG 439), skin corrosion (OECD TG 431) and eye irritation (OECD TG 438) performed with the major constituent, Ethyl-2‐methylpent‐3‐enoate, are presented and thereafter the read across justification.
Skin corrosion of Ethyl-2‐methylpent‐3‐enoate
In an in vitro skin corrosion test using a human skin model (EpiDerm Skin Model) performed according to OECD TG 431 and GLP principles, the influence of the test substance on the viability of human skin was tested. The test item was applied undiluted (50 μL) directly on top of the skin tissue. The positive control had a mean relative tissue viability of 7.2% after the 1-hour exposure. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within the acceptance limits of OECD 431 (lower acceptance limit ≥0.8 and upper acceptance limit ≤2.8) and the laboratory historical control data range. In the range of 20 - 100% viability the Coefficient of Variation between replicates of the negative control tissues was ≤ 14%, indicating that the test system functioned properly. The relative mean tissue viability obtained after 3-minute and 1-hour treatments with the test item compared to the negative control tissues was 98% and 65%, respectively. Because the mean relative tissue viability for the test item was not below 50% after the 3-minute treatment and not below 15% after the 1-hour treatment the test item is considered to be not corrosive. In conclusion, the test substance is not corrosive to the skin.
Skin irritation of Ethyl-2‐methylpent‐3‐enoate
In an in vitro skin irritation test using a human skin model (EPISKIN Standard Model) performed according to OECD TG 439 and GLP principles, the influence of the test substance on the viability of human skin was tested. The test item was applied undiluted (25 μL), directly on top of the skin tissue for 15 ± 0.5 minutes. After a 42 ± 1 hour post-incubation period, determination of the cytotoxic (irritancy) effect was performed. Skin irritation is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 15 ± 0.5 minutes treatment with the test item compared to the negative control tissues was 94%. Since the mean relative tissue viability for the test item was above 50% after 15 ± 0.5 minutes treatment the test item is considered to be non-irritant. The positive control had a mean cell viability of 5.4% after 15 ± 0.5 minutes exposure. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within the laboratory historical control data range. The standard deviation value of the percentage viability of three tissues treated identically was ≤ 4.2%, indicating that the test system functioned properly. In conclusion, the test substance is not irritating to the skin.
Eye irritation of Ethyl-2‐methylpent‐3‐enoate
An Isolated Chicken Eye Test (ICET) was performed with the substance according to OECD guideline 438 and in accordance with GLP principles. Thirty µL of the Substance was applied to corneas (n=3). After 10 seconds exposure time, the surface of the eyes was rinsed with physiological saline solution. Slight corneal swelling change (mean = -8.5%) was observed during the four-hour observation period on test item treated eyes. Slight cornea opacity change (severity 0.5 on one eye and severity 1 on two eyes) was observed. No fluorescein retention change was noted on all eyes. No other morphological effect was observed. The negative control and positive control results were within the historical data range. It was therefore concluded that the test conditions were adequate and that the test system functioned properly. Based on the results, the endpoints Corneal swelling and Corneal opacity were assigned ICE CLASS II and the Fluorescein retention endpoint was assigned ICE CLASS I. The substance is not an eye irritant.
Skin and eye irritation of Eth Oxanoate 369 Crude based on read-across from data available for Ethyl-2-methyl-3-pentenoate (CAS# 58625-89-1) its main constituent
Introduction and hypothesis for the analogue approach
The multi-constituent substance Eth Oxanoate 369 Crude consists of two main constituents: 62% Ethyl-2-methyl-3-pentenoate (CAS# 58625-89-1) and 32% Ethyl-2‐methylpentanoate (CAS# 39255-32-8). For Eth Oxanoate 369 Crude, no experimental skin and eye irritation data are available. In accordance with Article 13 of REACH, lacking information can be generated by means other than experimental testing, i.e. applying alternative methods such as, QSARs, grouping and read-across. For assessing the skin and eye irritation potential of Eth Oxanoate 369 Crude, the analogue approach is selected because for one of the constituents, Ethyl-2-methyl-3-pentenoate, reliable skin and eye irritation information are available which can be used for read-across.
Hypothesis: Eth Oxanoate 369 Crude has the same skin and eye irritation potential as Ethyl-2-methyl-3-pentenoate based on similarity in chemical structure, dermal absorption and reactivity.
Available information: For the major constituent (Ethyl-2‐methylpent‐3‐enoate), an in vitro skin irritation study (OECD TG 439) and an in vitro skin corrosion study (OECD TG 431) are available, both in compliance with GLP. Based on these studies the substance does not need to be classified for skin irritation. For this major constituent also an in vitro eye irritation study performed according to OECD TG 438 and in compliance with GLP resulting in absence of classification.
Target chemical and source chemical
Chemical structures of the target chemical and the source chemical are shown in the data matrix, including physico-chemical properties.
Purity / Impurities
The major and minor constituents of Eth Oxanoate 369 Crude are presented in the Data matrix. The impurities of Eth Oxanoate 369 Crude are < 10%.
Analogue approach justification
According to Annex XI 1.5, read-across can be used to replace testing when the similarity can be based on a common backbone and a common functional group. When using read-across the result derived should be applicable for C&L and/or risk assessment and it should be presented with adequate and reliable documentation, which is presented below.
Analogue selection: For Eth Oxanoate 369 Crude, the constituent Ethyl-2-methyl-3-pentenoate was selected as source chemical for read-across because it is the major constituent (62%) of Eth Oxanoate 369 Crude and experimental skin and eye irritation data are available.
Structural similarities and differences: The major constituent, Ethyl-2-methyl-3-has a molecular weight of 142 g/mol and has a similar structure to the minor constituent (32%), Ethyl-2‐methylpentanoate, which has a molecular weight of 144 g/mol. The only difference in their structures is that Ethyl-2-methyl-3-pentenoate has a double bond on the carbon 3 of the pentene ester.
Bioavailability for skin and eye tissue: The bioavailability of the constituents of Eth Oxanoate 369 Crude and Ethyl-2-methyl-3-pentenoate are expected to be very comparable based on the similarity in chemical structure and physico-chemical properties.
Irritation reactivity: The Ethyl-2-methyl-3-pentenoate will have similar reactivity compared to the minor constituent, the double bond in its structure not conjugated to the ester and the reactivity will be similar to the saturated alkyl chain of the minor constituent.
Uncertainty of the prediction: There are no uncertainties other than those already addressed above. The information on the ECHA dissemination site of the minor constituent presents absence of classification and labelling for skin and eye irritation (https://echa.europa.eu/nl/registration-dossier/-/registered-dossier/10528) further supports the read across.
Data matrix
The relevant information on physico-chemical properties and toxicological characteristics are presented in the data matrix below.
Conclusions on skin and eye irritation for hazard and risk assessment
For Eth Oxanoate 369 Crude no skin and eye irritation data is available. For its major constituent Ethyl-2-methyl-3-pentenoate such information is available which can be used for read-across to fill this data gap. When using read-across the result derived should be applicable for C&L and/or risk assessment and be presented with adequate and reliable documentation. This documentation is presented in the current text. For the analogue Ethyl-2-methyl-3-pentenoate, well conducted skin irritation, skin corrosion and eye irritation studies are available, showing no irritative or corrosive effects. This information can be directly used for read-across to Eth Oxanoate 369 Crude.
Final conclusion: Eth Oxanoate 369 Crude is not a skin or eye irritant.
Data matrix to support the read-across to Eth Oxanoate 369 Crude from Ethyl-2-methyl-3-pentenoate for skin and eye irritation
Endpoint | Eth Oxanoate 369 Crude | Ethyl-2-methyl-3-pentenoate | Ethyl-2‐methylpentanoate |
| Target | Major constituent Source | Minor constituent
|
Chemical structure | |||
CAS number | Not applicable | 58625-89-1 | 39255-32-8 |
EC number | 952-991-2 |
| 254-384-1 |
Typical conc. (%) | Not applicable | 62 | 32 |
REACH registered | - | registered | registered |
Empirical formula | Not applicable | C8H14O2
| C8H16O2 |
Molecular weight | 142 – 144 | 142 | 144 |
Phys-chem |
|
|
|
Log Kow | 3.0 (measured major constituent)* | 2.54 (EPISUITE) 3.1 (measured)* | 2.76 (EPISUITE) 2.09 (Echa dissemination site) |
Water Solubility (mg/L) | 612.3 (measured, major r constituent) | 612.3 (measured) | 467 (ECHA dissemination site |
Human health endpoints |
|
|
|
Skin corrosion | Read across from its major constituent | Negative (OECD TG 431) | Negative (ECHA dissemination site) |
Skin irritation | Read across from its major constituent | Negative (OECD TG 439) | Negative (ECHA dissemination site) |
Eye irritation | Read across from its major constituent | Negative (OECD TG 438, 2021) | Negative OECD TG 404 (ECHA dissemination site, 2012) |
Skin sensitisation | Read across from its major constituent | Negative (OECD 442C, 2021) Negative (OECD 442D, 2021)
| Not sensitising (ECHA dissemination site)
|
*the same substance is measured twice with log Kow 0.1 difference
Justification for classification or non-classification
Based on the results of the available in vitro skin and eye corrosion/irritation studies, the substance does not have to be classified for skin and eye irritation according to EU CLP (EC 1272/2008 and its amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.